Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)
China flag China · Delayed Price · Currency is CNY
25.78
+2.19 (9.28%)
May 29, 2026, 3:10 PM CST

SHE:300204 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
128.28123.6453.9185.18264.9985.01
Trading Asset Securities
-----381.46
Cash & Short-Term Investments
128.28123.6453.9185.18264.99466.47
Cash Growth
43.43%129.34%-36.71%-67.86%-43.19%-35.44%
Accounts Receivable
46.7441.5239.0761.22188.18157.9
Other Receivables
0.891.220.641.141.381.18
Receivables
47.6442.7539.7262.35189.56159.07
Inventory
19.5519.322.1820.9318.8325.01
Prepaid Expenses
-00.010.01--
Other Current Assets
66.9566.9761.870.4155.6937.9
Total Current Assets
262.42252.65177.62238.89529.06688.44
Property, Plant & Equipment
205.99211.79235261.36290.58312.43
Long-Term Investments
471.64475.02514.07549.54522.25545.43
Goodwill
19.7519.7519.7519.7519.7522.17
Other Intangible Assets
36.1636.3634.6735.1380.4882.22
Long-Term Deferred Tax Assets
50.4250.4250.08164198.13155.84
Long-Term Deferred Charges
201.4186.77117.8462.5726.975.29
Other Long-Term Assets
33.2133.450.580.982.0915.15
Total Assets
1,2811,2661,1501,3321,6691,827
Accounts Payable
14.6921.9233.4972.9135.8731.71
Accrued Expenses
20.4652.6967.7183.85158.73150.01
Short-Term Debt
50.0392.2742.4240.9523.09-
Current Portion of Leases
0.270.430.06-2.692.25
Current Income Taxes Payable
3.050--0.02-
Current Unearned Revenue
1.191.263.892.863.271.34
Other Current Liabilities
41.426.996.887.68.111.33
Total Current Liabilities
131.1175.55154.45208.17231.77196.64
Long-Term Leases
0.580.670.06-3.185.37
Long-Term Unearned Revenue
26.0226.7629.9129.2433.4721.32
Long-Term Deferred Tax Liabilities
49.2449.2448.4374.1447.0352.91
Other Long-Term Liabilities
210.23207.27----
Total Liabilities
486.07459.48232.85311.55315.45276.25
Common Stock
477.77477.77477.77477.77475.36476.03
Additional Paid-In Capital
558.6558.6570.95534.46519.36536.44
Retained Earnings
-335.56-327.12-249.37-83.63314.62510.98
Treasury Stock
------43.68
Comprehensive Income & Other
109.01111.53129.8892.0644.5370.97
Total Common Equity
809.82820.78929.231,0211,3541,551
Minority Interest
-14.91-14.06-12.47---
Shareholders' Equity
794.92806.72916.761,0211,3541,551
Total Liabilities & Equity
1,2811,2661,1501,3321,6691,827
Total Debt
119.7893.3642.5440.9528.967.63
Net Cash (Debt)
8.5130.2811.3744.23236.03458.84
Net Cash Growth
-87.74%166.24%-74.28%-81.26%-48.56%-31.98%
Net Cash Per Share
0.020.060.020.090.490.97
Filing Date Shares Outstanding
477.77477.77477.77477.77475.36472.66
Total Common Shares Outstanding
477.77477.77477.77477.77475.36472.66
Working Capital
131.3277.123.1830.72297.28491.8
Book Value Per Share
1.691.721.942.142.853.28
Tangible Book Value
753.91764.67874.81965.781,2541,446
Tangible Book Value Per Share
1.581.601.832.022.643.06
Buildings
-215.73215.93214.75184.57183.64
Machinery
-302.85317.62318.38254.98246.28
Construction In Progress
----87.8285.48